E-Case

JACC

Lots of interesting abstracts and cases were submitted for TCTAP 2025. Below are the accepted ones after a thorough review by our official reviewers. Don¡¯t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!

TCTAP C-211

Navigating the Crossroads: Successfully Managing a Cruciform Fistula After Transcaval TAVI

By Yu-Chuan Chuang

Presenter

Yu-Chuan Chuang

Authors

Yu-Chuan Chuang1

Affiliation

Taichung Veterans General Hospital, Taiwan1,
View Study Report
TCTAP C-211
Structural - Aortic Valve Intervention - Non-femoral TAVR

Navigating the Crossroads: Successfully Managing a Cruciform Fistula After Transcaval TAVI

Yu-Chuan Chuang1

Taichung Veterans General Hospital, Taiwan1,

Clinical Information

Patient initials or Identifier Number

Relevant Clinical History and Physical Exam

A 78-year-old man with end-stage renal disease from diabetic nephropathy and poorly controlled hypertension is on regular hemodialysis. His medical history also includes complex coronary artery disease with multiple interventions and peripheral arterial disease. Intermittent shortness of breath and heart failure symptoms have been reported for more than six months that are deemed to be related to low flow low gradient severe aortic stenosis.



Relevant Test Results Prior to Catheterization

The echocardiographic findings indicate an LVEF of 55%, an aortic valve area of 0.77 cm©÷, a maximum velocity of 3.28 m/s, a mean pressure gradient of 22 mmHg. Intermittent shortness of breath and heart failure symptoms have been reported for more than six months and are deemed to be related to low flow, low gradient severe aortic stenosis. His surgical risk, represented by an STS score of 12.4%, reinforces the decision to proceed with the TAVI intervention.

Relevant Catheterization Findings

However, multislice CT scan revealed severe stenosis and calcific change in bilateral femoral arteries, making the transfemoral arterial approach unfeasible. Alternative access sites, including bilateral carotid and axillary arteries, were also not feasible. Although there was severe calcification in the abdominal aorta, the transcaval approach targeting a calcium-free segment of the aorta at the L3 level represented barely the last resort for carrying out TAVI procedures.


Interventional Management

Procedural Step

The transcaval approach starts with descending abdominal aortography. A 7-F renal double curve guide catheter which was advanced through the right femoral vein. An Astato wire along with a CXI microcatheter were advanced through the catheter to the indexed L3 level for transcaval puncture with the distal end of the Astato guidewire connecting with an electrosurgery pencil. After the Astato guidewire cross the vena cava and the adjacent aortic wall, the Asatato-CXI system was then captured by a 25 mm Gooseneck snare placed at the corresponding aortic level through left femoral atery, and sent upward to the thoracic aortic level. The Asatato wire was exchanged for a Lunderquist guidewire, through which an 20 French long sheath was advanced through RFV to the abdominal aorta. Standard TAVI procedures employing a Navitor 27 mm transcatheter heart valve were then performed through this vena-aortic connection facilitated by LV on-wire pacing. At the end of the procedure, an Amplatzer Duct Occluder was deployed to close the aorto-caval tract, with post-procedural angiography confirming a patent fistula with cruciform contrast flow around the neck of the occluder but with contrast returning to the cava. After careful examination, there was no extravasation on the digital subtraction angiogram. The next day, a follow-up angiogram of the aorto-caval fistula was performed, which revealed a patent fistula but without extravasation. The patient is doing well during one year of follow-up.


Case Summary

Despitesevere peripheral vascular diseases and widespread calcification, the use ofthe transcaval approach allowed the successful implementation of thetranscatheter aortic valve. The post-operative course was uneventful in this patient, with nosignificant complications from the closure of the aorta-caval tract, and thepatient remained stable during a one-year follow-up. The case highlights thepotential of transcalative TAVI as a viable alternative for patients withsevere peripheral artery diseases and underscores the importance ofpersonalized strategies within the heart team to optimize clinical outcomes.